An experimental cancer-killing virus has been administered to a human patient for the first time, with hopes the testing will ultimately reveal evidence of a new means of successfully fighting cancer tumors in people's bodies.
Before efficacy is determined, however, researchers will first be looking to see how well the drug is handled by patients, recording the frequency and severity of any adverse effects, and also investigating how well participants fare as low doses are escalated.
Which doesn't mean we can't get excited about the broad potential here; just that we should keep our expectations in check, because promising results in pre-clinical experiments don't necessarily guarantee similarly successful results in subsequent research involving human patients. If the drug does turn out to be safe and well-tolerated, we could be looking at a powerful new tool for fighting tumors,
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
First human patient injected with revolutionary cancer-killing virusScientists are currently planning a trial for a new cancer-killing virus, and they'll be injecting humans with it for the first time.
Lire la suite »
First Human Landing On An Asteroid by 2073, Say ScientistsPeople alive today could witness astronauts visiting the asteroid belt within 50 years. Read all about it in one of our latest articles.
Lire la suite »
MTA to hold first town hall on Interborough Express plansIt's believed 88,000 people would use this Brooklyn-Queens route each day.
Lire la suite »
Meet the cool 62-year-old Kenyan on first all-Black team to summit Everest'We wanted to show the world that people of color can do something like this,' says James 'KG' Kagambi. He's a great believer in lessons learned from the outdoors — and glad his achy knees made it!
Lire la suite »
Abbott CEO apologizes for the formula shortage as the first overseas shipment arrives'We're sorry to every family we've let down,' wrote CEO Robert Ford. The shuttered plant at the heart of the shortage will reopen in June, but it may take months before production is back to normal.
Lire la suite »